Chirfi Guindo - May 2, 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Chief Marketing Officer
Signature
/s/ Kelly E. W. Grez, as attorney-in-fact for Chirfi Guindo
Stock symbol
MRK
Transactions as of
May 2, 2023
Transactions value $
$0
Form type
4
Date filed
5/4/2023, 05:43 PM
Previous filing
Aug 4, 2022
Next filing
Aug 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 1.43K May 2, 2023 Direct F1
holding MRK Common Stock-401(k) Plan 52.1 May 2, 2023 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +34.6K $0.00 34.6K May 2, 2023 Common Stock 34.6K $117.89 Direct F3

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Includes shares acquired and dividends earned through April 10, 2023 in the Merck U.S. Savings Plan, a 401(k) plan.
F3 The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.